(Q69861902)

English

Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group

scientific article published on 01 April 1985

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

title

Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

main subject

phase II clinical trial

1 reference

1 reference

1 April 1985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

published in

Cancer Treatment Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

volume

69

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

page(s)

417-420

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 October 2019

Identifiers

PubMed publication ID

2859924

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2859924

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2859924%20AND%20SRC:MED&resulttype=core&format=json

(Q69861902)

Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)